CA2+-DEPENDENT INTERACTIONS BETWEEN GLA AND EGF DOMAINS IN HUMAN COAGULATION FACTOR-IX

被引:22
作者
MEDVED, LV [1 ]
VYSOTCHIN, A [1 ]
INGHAM, KC [1 ]
机构
[1] AMER RED CROSS,J HOLLAND LAB,15601 CRABBS BRANCH WAY,ROCKVILLE,MD 20855
关键词
D O I
10.1021/bi00168a012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Ca2+-induced interaction between the Gla and EGF domains of human factor IX was investigated by means of three fragments: 6-kDa Gla, 19-kDa (EGF)2, and 25-kDa Gla-(EGF)2. Size-exclusion chromatography and spectroscopic measurements revealed that the Gla-EGF interaction is rather strong; it can be reconstituted by mixing the 6-kDa and 19-kDa fragments which form a stable 1:1 heterocomplex in the presence of Ca2+. By itself, the 6-kDa Gla self-associates in these conditions. The Gla-EGF interaction can be disrupted in 5 M urea where the compact structure of both domains is preserved. Binding of Ca2+ to 19-kDa (EGF)2 occurred with a K(d) of 71 muM in the absence and 108 muM in the presence of 5 M urea and stabilized the first EGF domain, increasing its T(m) by 12-degrees-C. Addition of Ca2+ to the 6-kDa and 25-kDa fragments produced biphasic changes in their fluorescence; the intensity increased slightly at low Ca2+ concentration and then decreased in a monotonic manner. In 5 M urea, only the decrease occurred, with apparent K(d)s of 0.33 and 0.30 mM for 6-kDa Gla and 25-kDa Gla-(EGF)2, respectively. Thus, in 5 M urea in the presence of Ca2+, the isolated Gla domain has a compact structure and Ca2+ binding properties similar to those in the 25-kDa fragment. In the absence of urea, the Gla domain interacts either with itself, when isolated, or with the first EGF domain when present, as in the 6-kDa/19-kDa heterocomplex, in the 25-kDa fragment and presumably intact factor IX.
引用
收藏
页码:478 / 485
页数:8
相关论文
共 29 条
[1]  
ASTERMARK J, 1991, J BIOL CHEM, V266, P2430
[2]  
BARON M, 1992, PROTEIN SCI, V1, P81
[3]  
BROWNLEE GG, 1992, PROTEIN SCI, V1, P81
[4]   THE COAGULATION CASCADE - INITIATION, MAINTENANCE, AND REGULATION [J].
DAVIE, EW ;
FUJIKAWA, K ;
KISIEL, W .
BIOCHEMISTRY, 1991, 30 (43) :10363-10370
[5]   NUCLEOTIDE-SEQUENCE OF THE GENE FOR HUMAN-PROTHROMBIN [J].
DEGEN, SJF ;
DAVIE, EW .
BIOCHEMISTRY, 1987, 26 (19) :6165-6177
[6]   THE MOLECULAR-BASIS OF BLOOD-COAGULATION [J].
FURIE, B ;
FURIE, BC .
CELL, 1988, 53 (04) :505-518
[7]   THE 1ST EGF-LIKE DOMAIN FROM HUMAN FACTOR-IX CONTAINS A HIGH-AFFINITY CALCIUM-BINDING SITE [J].
HANDFORD, PA ;
BARON, M ;
MAYHEW, M ;
WILLIS, A ;
BEESLEY, T ;
BROWNLEE, GG ;
CAMPBELL, ID .
EMBO JOURNAL, 1990, 9 (02) :475-480
[8]   VITAMIN-K-DEPENDENT BLOOD-COAGULATION PROTEINS FORM HETERO-DIMERS [J].
HARLOS, K ;
HOLLAND, SK ;
BOYS, CWG ;
BURGESS, AI ;
ESNOUF, MP ;
BLAKE, CCF .
NATURE, 1987, 330 (6143) :82-84
[9]   SEQUENCE-SPECIFIC H-1-NMR ASSIGNMENTS, SECONDARY STRUCTURE, AND LOCATION OF THE CALCIUM-BINDING SITE IN THE 1ST EPIDERMAL GROWTH-FACTOR LIKE DOMAIN OF BLOOD-COAGULATION FACTOR-IX [J].
HUANG, LH ;
CHENG, H ;
PARDI, A ;
TAM, JP ;
SWEENEY, WV .
BIOCHEMISTRY, 1991, 30 (30) :7402-7409
[10]   CALCIUM-BINDING AND PUTATIVE ACTIVITY OF THE EPIDERMAL GROWTH-FACTOR DOMAIN OF BLOOD-COAGULATION FACTOR-IX [J].
HUANG, LH ;
KE, XH ;
SWEENEY, W ;
TAM, JP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 160 (01) :133-139